SeminarPast EventBrain Imaging

Multimodal brain imaging to predict progression of Alzheimer’s disease

Schedule
Monday, December 7, 2020
11:00 UTC
Karl Herholz

Prof

University of Manchester, Division of Neuroscience and Experimental Psychology

Host: ICM Paris Brain Institute

Event Information

Host

ICM Paris Brain Institute

Duration

70 minutes

Abstract

Cross-sectional and longitudinal multimodal brain imaging studies using positron emission tomography (PET) and magnetic resonance imaging (MRI) have provided detailed insight into the pathophysiological progression of Alzheimer’s disease. It starts at an asymptomatic stage with widespread gradual accumulation of beta-amyloid and spread of pathological tau deposits. Subsequently changes of functional connectivity and glucose metabolism associated with mild cognitive impairment and brain atrophy may develop. However, the rate of progression to a symptomatic stage and ultimately dementia varies considerably between individuals. Mathematical models have been developed to describe disease progression, which may be used to identify markers that determine the current stage and likely rate of progression. Both are very important to improve the efficacy of clinical trials. In this lecture, I will provide an overview on current research and future perspectives in this area.

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.